Dysplastic versus proliferative CMML – a retrospective analysis of 91 patients from a single institution
- 1 September 2001
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 25 (9) , 741-747
- https://doi.org/10.1016/s0145-2126(01)00014-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- Cross‐validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogeneticsBritish Journal of Haematology, 1999
- Problems in the classification of CMML—dysplastic versus proliferative typeLeukemia Research, 1998
- FAB classification of myelodysplastic syndromes: merits and controversiesAnnals of Hematology, 1995
- The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia GroupBritish Journal of Haematology, 1994
- Point of View: Chronic Myelomonocytic Leukaemia (CMML)–A Myelodysplastic or Myeloproliferative Syndrome?Leukemia & Lymphoma, 1993
- Myelodysplastic syndromes: a scoring system with prognostic significanceBritish Journal of Haematology, 1985
- Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 casesBlood, 1984
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958